Nicky Kelepouris, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2300 Computer Rd, Suite H-39, Willow Grove, PA 19090 Phone: 215-675-5200 Fax: 215-657-8083 |
Glenn Alan Mcgrath, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd, Suite H-39, Willow Grove, PA 19090 Phone: 215-657-5200 Fax: 215-657-8083 |
Peter J Gkonos, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2300 Computer Rd, Suite H-39, Willow Grove, PA 19090 Phone: 215-657-5200 Fax: 215-657-8083 |
Dr. Melissa L.a. Sawyer Falcon, D.O Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd Ste H39, Willow Grove, PA 19090 Phone: 215-657-5200 Fax: 215-657-8083 |
Dr. Brian Walter Beluch, D.O. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2300 Computer Rd Ste H39, Willow Grove, PA 19090 Phone: 215-657-5200 Fax: 215-657-8083 |
News Archive
The need to set national sanitary standards on the pallet industry to curb the threat of contamination to the U.S. food supply was drawn into sharp relief by a just-issued report by the Produce Safety Project showing acute foodborne illness costs the nation $152 billion annually in healthcare, workplace and other economic losses.
Acute myeloid leukemia is one of the most aggressive cancers. While other cancers have benefited from new treatments, there has been no encouraging news for most leukemia patients for the past 40 years. Until now.
Henry Ford Health System's Department of Neurosurgery was awarded a $600,000 grant by the Department of Defense to study the genetic makeup of gliomas, a type of brain cancer, in hope of identifying new therapies.
Ascent Therapeutics announced today that the Company has demonstrated efficacy in preclinical models in two Pepducin projects. One of the projects targets CXCR4, a key regulator of stem cell and inflammatory cell homeostasis. A second project has yielded the first potent Pepducin agonists for an undisclosed cardiovascular target.
Catheter Connections, a start-up company co-founded by nurses seeking to reduce deadly hospital-acquired bloodstream infections, announced today the issuance of U.S. Patent Number 8,343,112.
› Verified 3 days ago